BioCentury | Aug 1, 2011
Clinical News

EHT Dx14 diagnostic data

...tissue fine needle aspirate (FNA) samples for which cytological analysis gave indeterminate results showed that EHT Dx14...
...96.1% sensitivity. ExonHit previously reported data from the first phase of the study showing that EHT Dx14...
...to detect breast cancer (see BioCentury, June 1, 2009). ExonHit S.A. (Euronext:ALEHT), Paris, France Product: EHT Dx14...
BioCentury | Jul 4, 2011
Finance

3Q Financial Markets Preview: Flavored with Phase III

...XL184 Medullary thyroid cancer (MTC) Ph III data; submit NDA Mid-2011; 2H11 ExonHit S.A. (Euronext:ALEHT) EHT Dx14...
BioCentury | Apr 11, 2011
Clinical News

EHT Dx14 diagnostic data

...47 benign and 47 malignant breast tissue fine needle aspirate (FNA) samples showed that ExonHit's EHT Dx14...
...detect breast cancer (see BioCentury, June 1, 2009). ExonHit Therapeutics S.A. (Euronext:ALEHT), Paris, France Product: EHT Dx14...
Items per page:
1 - 3 of 3